GlucoTrack, Inc. (GCTK)
2.97
+0.04
(+1.37%)
USD |
NASDAQ |
Sep 09, 09:57
GlucoTrack Enterprise Value : 2.058M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 2.058M |
| September 04, 2026 | 2.079M |
| September 03, 2026 | 2.220M |
| September 02, 2026 | 2.308M |
| September 01, 2026 | 2.371M |
| August 31, 2026 | 2.608M |
| August 28, 2026 | 2.600M |
| August 27, 2026 | 2.626M |
| August 26, 2026 | 2.845M |
| August 25, 2026 | 2.964M |
| August 24, 2026 | 2.916M |
| August 21, 2026 | 3.010M |
| August 20, 2026 | 2.973M |
| August 19, 2026 | 3.018M |
| August 18, 2026 | 2.994M |
| August 17, 2026 | 2.976M |
| August 14, 2026 | 3.135M |
| August 13, 2026 | 3.123M |
| August 12, 2026 | 3.194M |
| August 11, 2026 | 3.161M |
| August 10, 2026 | 3.357M |
| August 07, 2026 | 3.540M |
| August 06, 2026 | 3.786M |
| August 05, 2026 | 4.121M |
| August 04, 2026 | 4.582M |
| Date | Value |
|---|---|
| August 03, 2026 | 3.432M |
| July 31, 2026 | 3.821M |
| July 30, 2026 | 5.717M |
| July 29, 2026 | 2.619M |
| July 28, 2026 | 2.713M |
| July 27, 2026 | 2.737M |
| July 24, 2026 | 2.658M |
| July 23, 2026 | 2.790M |
| July 22, 2026 | 2.750M |
| July 21, 2026 | 3.182M |
| July 20, 2026 | 3.395M |
| July 17, 2026 | 3.915M |
| July 16, 2026 | 3.965M |
| July 15, 2026 | 4.146M |
| July 14, 2026 | 4.147M |
| July 13, 2026 | 3.737M |
| July 10, 2026 | 3.448M |
| July 09, 2026 | 3.267M |
| July 08, 2026 | 3.127M |
| July 07, 2026 | 3.088M |
| July 06, 2026 | 2.825M |
| July 02, 2026 | 2.838M |
| July 01, 2026 | 3.011M |
| June 30, 2026 | 2.832M |
| June 29, 2026 | 0.4466M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Nuwellis, Inc. | -3.259M |
| Abbott Laboratories | 210.25B |
| DexCom, Inc. | 31.35B |
| Insulet Corp. | 10.28B |
| AngioDynamics, Inc. | 591.77M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.814M |
| Total Expenses (Quarterly) | 3.814M |
| EPS Diluted (Quarterly) | -11.42 |
| Earnings Yield | -6.07K% |
| Normalized Earnings Yield | -6075.94 |